Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.26
(-3.4%)
CNY 4.26
(-3.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.06 Million | 123.26 Million | 123.83 Million | -271.68 Million | 36.17 Million | 350.93 Million |
| Net Income | -206.5 Million | -100.88 Million | -201.63 Million | -1.04 Billion | -921.55 Million | 198.53 Million |
| Depreciation & Amortization | 44.46 Million | 55.4 Million | 107.47 Million | 81.45 Million | 76.44 Million | 92.62 Million |
| Deferred income taxes | 21.14 Million | -5.38 Million | 37.18 Million | -6.28 Million | -5.11 Million | -28.46 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 97.04 Million | 72.51 Million | 321.94 Million | 158.54 Million | 498.85 Million | -53.11 Million |
| Other non-cash items | 44.39 Million | 96.22 Million | -103.94 Million | 535.97 Million | 382.42 Million | 112.89 Million |
| Investing Cash Flow | -9.36 Million | 221.73 Million | 272.65 Million | 442.71 Million | -50.81 Million | -199.73 Million |
| Investments in PPE | -10.41 Million | -13.51 Million | -38.11 Million | -96.04 Million | -113.63 Million | -171.11 Million |
| Acquisitions | -4 Million | 63.6 Million | 253.39 Million | 434.17 Million | 135.57 Million | -10.06 Million |
| Investment purchases | - | -0.32 | 0.88 | -250 Million | -322 Million | -120 Million |
| Sales/Maturities of investments | 5.05 Million | 53.31 Million | 45.36 Million | 352.59 Million | 231.82 Million | 100.62 Million |
| Other Investing Activities | -11.52 Million | 118.33 Million | 12.01 Million | 1.98 Million | 17.42 Million | 814.01 Thousand |
| Financing Cash Flow | -192.97 Million | -336.17 Million | -387.26 Million | -414.71 Million | -94.02 Million | -112.56 Million |
| Debt repayment | -15.71 Million | -454.22 Million | -585.32 Million | -1.21 Billion | -1.25 Billion | -820.2 Million |
| Dividends payments | -23.61 Million | -39.63 Million | -91.48 Million | -89.24 Million | -86.55 Million | -102.13 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -153.65 Million | 157.68 Million | 289.54 Million | 889.43 Million | 1.24 Billion | 809.76 Million |
| Accounts receivables | 37.39 Million | 54.92 Million | 254.91 Million | 274.01 Million | 449.73 Million | -93.7 Million |
| Accounts payables | 823.41 Thousand | -54.92 Million | -254.91 Million | -191.91 Million | -449.73 Million | 61.18 Million |
| Inventory | 37.69 Million | 37.27 Million | 69.37 Million | 82.36 Million | -58.7 Million | 7.87 Million |
| Other working capital | 21.96 Million | 35.23 Million | 252.57 Million | -5.92 Million | 557.55 Million | -60.98 Million |
| Cash at beginning of period | 177.91 Million | 168.93 Million | 159.76 Million | 405.47 Million | 512.1 Million | 472.12 Million |
| Cash at end of period | 10.53 Million | 177.91 Million | 168.93 Million | 159.76 Million | 405.47 Million | 512.1 Million |
| Capital Expenditure | -10.41 Million | -13.51 Million | -38.11 Million | -96.04 Million | -113.63 Million | -171.11 Million |
| Effect of forex changes on cash | -92.47 Thousand | 151.21 Thousand | -55.43 Thousand | -2.02 Million | 2.03 Million | 1.34 Million |
| Net cash flow / Change in cash | -167.37 Million | 8.97 Million | 9.17 Million | -245.71 Million | -106.63 Million | 39.98 Million |
| Free Cash Flow | 24.64 Million | 109.75 Million | 85.71 Million | -367.72 Million | -77.46 Million | 179.82 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -82.52 Million | -27.3 Million | 3.5 Million | -206.5 Million | -179.67 Million | -22.62 Million |
| Depreciation & Amortization | - | 7.95 Million | 7.95 Million | 44.46 Million | 44.46 Million | -22.69 Million |
| Deferred income taxes | - | - | - | 21.14 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 97.04 Million | 75.08 Million | 2.58 Million |
| Other non-cash items | 89 Million | 43.04 Million | 5.13 Million | 44.39 Million | 55.97 Million | 68.18 Million |
| Investing Cash Flow | 277.7 Thousand | -245.48 Thousand | -415.9 Thousand | -9.36 Million | 2.61 Million | -2.53 Million |
| Investments in PPE | -347.28 Thousand | -251.58 Thousand | -587.7 Thousand | -10.41 Million | -3.29 Million | -834.42 Thousand |
| Acquisitions | 650 Thousand | 6100.00 | 171.8 Thousand | -4 Million | 8.8 Million | -2.6 Million |
| Investment purchases | -25 Thousand | - | - | - | - | 1.00 |
| Sales/Maturities of investments | - | - | - | 5.05 Million | 5.02 Million | 1866.45 |
| Other Investing Activities | - | 6100.00 | 171.8 Thousand | -11.52 Million | -2.89 Million | 905.59 Thousand |
| Financing Cash Flow | -1.16 Million | -7.35 Million | -5.3 Million | -192.97 Million | -158.98 Million | -10.7 Million |
| Debt repayment | -3.84 Million | -2.34 Million | -1.49 Million | -15.71 Million | -8.27 Million | -17.34 Million |
| Dividends payments | - | -3.17 Million | -3.8 Million | -23.61 Million | -13.05 Million | -3.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.01 Million | -5 Million | -3.8 Million | -153.65 Million | -154.2 Million | 9.99 Million |
| Accounts receivables | - | - | - | 37.39 Million | 37.39 Million | 18.52 Million |
| Accounts payables | - | - | - | 823.41 Thousand | - | - |
| Inventory | - | - | - | 37.69 Million | 37.69 Million | -15.93 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 16.09 Million | 14.92 Million | 12.95 Million | 177.91 Million | 174.64 Million | 162.42 Million |
| Cash at end of period | 21.64 Million | 16.09 Million | 14.92 Million | 10.53 Million | 10.53 Million | 174.64 Million |
| Capital Expenditure | -347.28 Thousand | -251.58 Thousand | -587.7 Thousand | -10.41 Million | -3.29 Million | -834.42 Thousand |
| Effect of forex changes on cash | - | 979.05 Thousand | -957.81 Thousand | -92.47 Thousand | -93.88 Thousand | -299.52 |
| Net cash flow / Change in cash | 5.55 Million | 1.16 Million | 1.96 Million | -167.37 Million | -164.11 Million | 12.22 Million |
| Free Cash Flow | 6.12 Million | 7.53 Million | 8.05 Million | 24.64 Million | -7.45 Million | 24.62 Million |
UTAR
272450
TCRI
OVZON
0922
VLE